Collaborate Disseminate
Following years of regulatory delays and court battles the US Food and Drug Administration (FDA) has finally called for all e-cigarette products from leading company Juul to be removed from sale in the United States. The FDA cited the primary reason fo… Continue reading FDA bans Juul e-cigs after “insufficient” data on harmful chemicals
The FDA has followed highly promising results from trials demonstrating the hair regrowth potential of a common arthritis drug with a landmark approval, giving baricitinib the green light as a treatment for severe alopecia areata. The move makes the dr… Continue reading FDA approves first-of-a-kind hair loss drug for severe alopecia
Cybersecurity threats against health care have skyrocketed in recent years.
The post Senators push for more frequent medical device cybersecurity guidance from FDA appeared first on CyberScoop.
Continue reading Senators push for more frequent medical device cybersecurity guidance from FDA
A new direct-to-consumer test designed to detect a number of different respiratory viruses, including COVID-19 and influenza, has been authorized by the US Food and Drug Administration (FDA). The test is the first of its kind to be approved by the FDA … Continue reading First at-home test for flu, COVID and RSV authorized by the FDA
The U.S. Food and Drug Administration (FDA) has approved a new kind of treatment for type 2 diabetes. The once-weekly injection, called Mounjaro (tirzepatide), was found to be more effective at controlling blood sugar levels than other current treatmen… Continue reading FDA approves new kind of diabetes drug with anti-obesity potential
The U.S. Food and Drug Administration (FDA) has approved a new test for Alzheimer’s disease. The test is the first in vitro diagnostic tool for Alzheimer’s to be approved for use in the United States measuring amyloid protein levels in spinal fluid.
Tags: Diagnostic devices, Alzheimer’s Disease, Dementia, FDA, New Atlas Audio
Continue reading FDA clears new test for early detection of Alzheimer’s disease
The first breath-based COVID-19 test has been issued an emergency use authorization by the U.S. Food and Drug Administration (FDA). The device takes three minutes to return results and has been found to be over 90 percent accurate in detecting positive… Continue reading First COVID-19 breath test authorized for use in United States
The U.S. Food and Drug Administration (FDA) has authorized a new Fitbit feature designed to continuously monitor a wearer’s heart rhythms for signs of atrial fibrillation. The roll-out is based on a massive study that last year reported the Fitbit algo… Continue reading FDA approves new Fitbit continuous heart rate monitoring algorithm
New modeling from the Centers for Disease Control and Prevention (CDC) estimates the BA.2 Omicron variant is now dominant in the United States. In related news, the Food and Drug Administration (FDA) has withdrawn its emergency use authorization for th… Continue reading FDA pulls COVID antibody therapy as BA.2 variant becomes dominant in US
The U.S. Food and Drug Administration (FDA) has authorized a fourth mRNA vaccine dose for all individuals aged 50 and over. The authorization includes both Pfizer and Moderna vaccines and is recommended to be administered at least four months after a t… Continue reading Fourth COVID-19 mRNA vaccine dose approved for all older Americans